ElevateBio secures $150m to move cell and gene therapy companies forward amid ‘overwhelming’ CMO demand 06-Jun-2019 By Melissa Fassbender ElevateBio’s BaseCamp facility will provide “bench-to-bedside” services to its portfolio and partner companies – as the demand for cell and gene therapy CMOs “far outweighs the capacity,” says CEO.